{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T23:09:12Z","timestamp":1789427352823,"version":"build-2803163510"},"reference-count":107,"publisher":"Elsevier BV","issue":"36","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.vaccine.2017.07.045","type":"journal-article","created":{"date-parts":[[2017,7,28]],"date-time":"2017-07-28T05:31:32Z","timestamp":1501219892000},"page":"4659-4669","source":"Crossref","is-referenced-by-count":100,"title":["Immune correlates of protection for dengue: State of the art and research agenda"],"prefix":"10.1016","volume":"35","author":[{"given":"Leah C.","family":"Katzelnick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph","family":"Baric","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth-Ann","family":"Coller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josefina","family":"Coloma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"James E.","family":"Crowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek A.T.","family":"Cummings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hansi","family":"Dean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aravinda","family":"de Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Diamond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Durbin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Ferguson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter B.","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aubree","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duane J.","family":"Gubler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Guy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Elizabeth","family":"Halloran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Halstead","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Jarman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shee-mei","family":"Lok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelson L.","family":"Michael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eng Eong","family":"Ooi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios","family":"Papadopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley","family":"Plotkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander R.","family":"Precioso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Reiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix A.","family":"Rey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Rodr\u00edguez-Barraquer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Rothman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander C.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin","family":"Screaton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Sette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cameron","family":"Simmons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley L.","family":"St. John","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wellington","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Torresi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John S.","family":"Tsang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten","family":"Vannice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Whitehead","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annelies","family":"Wilder-Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In","family":"Kyu Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2017.07.045_b0005","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nature12060","article-title":"The global distribution and burden of dengue","volume":"496","author":"Bhatt","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2017.07.045_b0010","unstructured":"WHO\/TDR. Dengue: Guidelines for diagnosis, treatment, prevention and control \u2013 New Edition. Geneva, 2009."},{"key":"10.1016\/j.vaccine.2017.07.045_b0015","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1093\/infdis\/140.4.527","article-title":"In vivo enhancement of dengue virus infection in rhesus monkeys by passively transferred antibody","volume":"140","author":"Halstead","year":"1979","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.07.045_b0020","doi-asserted-by":"crossref","first-page":"444","DOI":"10.4269\/ajtmh.1989.40.444","article-title":"Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever","volume":"40","author":"Kliks","year":"1989","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2017.07.045_b0025","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1093\/oxfordjournals.aje.a113932","article-title":"Risk factors in dengue shock syndrome: A prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak","volume":"120","author":"Sangkawibha","year":"1984","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2017.07.045_b0030","doi-asserted-by":"crossref","first-page":"910","DOI":"10.4269\/ajtmh.2007.77.910","article-title":"Analysis of repeat hospital admissions for dengue to estimate the frequency of third or fourth dengue infections resulting in admissions and dengue hemorrhagic fever, and serotype sequences","volume":"77","author":"Gibbons","year":"2007","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2017.07.045_b0035","doi-asserted-by":"crossref","first-page":"e2274","DOI":"10.1371\/journal.pntd.0002274","article-title":"Correlation between dengue-specific neutralizing antibodies and serum avidity in primary and secondary dengue virus 3 natural infections in humans","volume":"7","author":"Puschnik","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2017.07.045_b0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0002451","article-title":"Analysis of cross-reactive antibodies recognizing the fusion loop of envelope protein and correlation with neutralizing antibody titers in Nicaraguan dengue cases","volume":"7","author":"Lai","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2017.07.045_b0045","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1073\/pnas.1522136113","article-title":"Neutralizing antibody titers against dengue virus correlate with protection from symptomatic infection in a longitudinal cohort","volume":"113","author":"Katzelnick","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2017.07.045_b0050","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3201\/eid1302.060539","article-title":"Neutralizing antibodies after infection with dengue 1 virus","volume":"13","author":"Guzman","year":"2007","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2017.07.045_b0055","doi-asserted-by":"crossref","first-page":"20130414","DOI":"10.1098\/rsif.2013.0414","article-title":"Interactions between serotypes of dengue highlight epidemiological impact of cross-immunity","volume":"10","author":"Reich","year":"2013","journal-title":"J R Soc Interface"},{"key":"10.1016\/j.vaccine.2017.07.045_b0060","doi-asserted-by":"crossref","first-page":"e2357","DOI":"10.1371\/journal.pntd.0002357","article-title":"Symptomatic versus inapparent outcome in repeat dengue virus infections is influenced by the time interval between infections and study year","volume":"7","author":"Montoya","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2017.07.045_b0065","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1093\/infdis\/jit436","article-title":"A shorter time interval between first and second dengue infections is associated with protection from clinical illness in a school-based cohort in Thailand","volume":"209","author":"Anderson","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.07.045_b0070","doi-asserted-by":"crossref","first-page":"e3230","DOI":"10.1371\/journal.pntd.0003230","article-title":"Dengue virus neutralizing antibody levels associated with protection from infection in Thai cluster studies","volume":"8","author":"Buddhari","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2017.07.045_b0075","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1093\/aje\/kwf005","article-title":"Epidemiology of inapparent and symptomatic acute dengue virus infection: A prospective study of primary school children in Kamphaeng Phet, Thailand","volume":"156","author":"Endy","year":"2002","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2017.07.045_b0080","doi-asserted-by":"crossref","first-page":"e670","DOI":"10.1371\/journal.pntd.0000670","article-title":"Epidemiology of dengue virus in Iquitos, Peru 1999 to 2005: Interepidemic and epidemic patterns of transmission","volume":"4","author":"Morrison","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2017.07.045_b0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2014.00280","article-title":"Epidemiological risk factors associated with high global frequency of inapparent dengue virus infections","volume":"5","author":"Grange","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2017.07.045_b0090","doi-asserted-by":"crossref","first-page":"e2462","DOI":"10.1371\/journal.pntd.0002462","article-title":"The Nicaraguan pediatric dengue cohort study: Incidence of inapparent and symptomatic dengue virus infections, 2004\u20132010","volume":"7","author":"Gordon","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2017.07.045_b0095","doi-asserted-by":"crossref","first-page":"e1000171","DOI":"10.1371\/journal.pmed.1000171","article-title":"A prospective nested case-control study of dengue in infants: Rethinking and refining the antibody-dependent enhancement dengue hemorrhagic fever model","volume":"6","author":"Libraty","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.vaccine.2017.07.045_b0100","doi-asserted-by":"crossref","first-page":"e0004262","DOI":"10.1371\/journal.pntd.0004262","article-title":"Epidemiology of infant dengue cases illuminates serotype-specificity in the interaction between immunity and disease, and changes in transmission dynamics","volume":"9","author":"Clapham","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2017.07.045_b0105","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1086\/590117","article-title":"Dengue in Vietnamese infants\u2013results of infection-enhancement assays correlate with age-related disease epidemiology, and cellular immune responses correlate with disease severity","volume":"198","author":"Chau","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.07.045_b0110","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1086\/648407","article-title":"Dengue virus infections and maternal antibody decay in a prospective birth cohort study of Vietnamese infants","volume":"200","author":"Chau","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.07.045_b0115","doi-asserted-by":"crossref","first-page":"411","DOI":"10.4269\/ajtmh.1988.38.411","article-title":"Evidence that maternal dengue antibodies are important in the development of dengue hemorrhagic fever in infants","volume":"38","author":"Kliks","year":"1988","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2017.07.045_b0120","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1093\/infdis\/jiw099","article-title":"Homotypic dengue virus reinfections in Nicaraguan children","volume":"214","author":"Waggoner","year":"2016","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.07.045_b0125","doi-asserted-by":"crossref","first-page":"611","DOI":"10.4269\/ajtmh.13-0600","article-title":"Lineage II of Southeast Asian\/American DENV-2 is associated with a severe dengue outbreak in the Peruvian Amazon","volume":"91","author":"Williams","year":"2014","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2017.07.045_b0130","doi-asserted-by":"crossref","first-page":"e0004398","DOI":"10.1371\/journal.pntd.0004398","article-title":"Incomplete protection against dengue virus type 2 re-infection in Peru","volume":"10","author":"Forshey","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2017.07.045_b0135","first-page":"45","article-title":"Dengue virus virulence and transmission determinants","volume":"338","author":"Rico-Hesse","year":"2010","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2017.07.045_b0140","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1128\/CVI.00208-07","article-title":"Primary and secondary infections of Macaca fascicularis monkeys with Asian and American genotypes of dengue virus 2","volume":"15","author":"Bernardo","year":"2008","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2017.07.045_b0145","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1093\/infdis\/jiv759","article-title":"Dengue virus (DENV) neutralizing antibody kinetics in children after symptomatic primary and postprimary DENV infection","volume":"213","author":"Clapham","year":"2016","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.07.045_b0150","doi-asserted-by":"crossref","first-page":"e0005554","DOI":"10.1371\/journal.pntd.0005554","article-title":"Dissecting the human serum antibody response to secondary dengue virus infections","volume":"11","author":"Patel","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2017.07.045_b0155","doi-asserted-by":"crossref","first-page":"7348","DOI":"10.1128\/JVI.00273-15","article-title":"Complexity of neutralizing antibodies against multiple dengue virus serotypes after heterotypic immunization and secondary infection revealed by in-depth analysis of cross-reactive antibodies","volume":"89","author":"Tsai","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2017.07.045_b0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12889-015-1590-z","article-title":"Sequential dengue virus infections detected in active and passive surveillance programs in Thailand, 1994\u20132010","volume":"15","author":"Bhoomiboonchoo","year":"2015","journal-title":"BMC Publ Health"},{"key":"10.1016\/j.vaccine.2017.07.045_b0165","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1093\/infdis\/jit273","article-title":"Reduced risk of disease during postsecondary dengue virus infections","volume":"208","author":"Olkowski","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.07.045_b0170","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2471\/BLT.07.040170","article-title":"Reconstructing historical changes in the force of infection of dengue fever in Singapore: Implications for surveillance and control","volume":"86","author":"Egger","year":"2008","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2017.07.045_b0175","doi-asserted-by":"crossref","first-page":"e1000139","DOI":"10.1371\/journal.pmed.1000139","article-title":"The impact of the demographic transition on dengue in Thailand: Insights from a statistical analysis and mathematical modeling","volume":"6","author":"Cummings","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.vaccine.2017.07.045_b0180","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1128\/CMR.11.3.480","article-title":"Dengue and dengue hemorrhagic fever","volume":"11","author":"Gubler","year":"1998","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2017.07.045_b0185","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1016\/j.vaccine.2013.12.040","article-title":"Evaluation of dengue virus strains for human challenge studies","volume":"32","author":"Mammen","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.07.045_b0190","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1126\/scitranslmed.aaf1517","article-title":"The live attenuated dengue vaccine TV003 elicits complete protection against dengue in a human challenge model","volume":"8","author":"Kirkpatrick","year":"2016","journal-title":"Sci Trans Med"},{"key":"10.1016\/j.vaccine.2017.07.045_b0195","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1146\/annurev-immunol-031210-101315","article-title":"Immune response to dengue virus and prospects for a vaccine","volume":"29","author":"Murphy","year":"2011","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.vaccine.2017.07.045_b0200","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.1016\/j.vaccine.2015.12.073","article-title":"Status of vaccine research and development of vaccines for dengue","volume":"34","author":"Vannice","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.07.045_b0205","doi-asserted-by":"crossref","first-page":"302","DOI":"10.4269\/ajtmh.2009.80.302","article-title":"Evaluation of interferences between dengue vaccine serotypes in a monkey model","volume":"80","author":"Guy","year":"2009","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2017.07.045_b0210","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiw576","article-title":"Dissecting antibodies induced by a chimeric yellow fever-dengue, live-attenuated, tetravalent dengue vaccine (CYD-TDV) in na\u00efve and dengue exposed individuals","author":"Henein","year":"2016","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.07.045_b9000","article-title":"Summit on dengue immune correlates of protection","volume":"1","author":"Durbin","year":"2016","journal-title":"Pers Commun"},{"key":"10.1016\/j.vaccine.2017.07.045_b0215","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.1016\/j.vaccine.2011.03.057","article-title":"Live-attenuated, tetravalent dengue vaccine in children, adolescents and adults in a dengue endemic country: Randomized controlled phase I trial in the Philippines","volume":"29","author":"Capeding","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.07.045_b0220","unstructured":"SAGE Working Group on Dengue Vaccines and World Health Organization Secretariat. Background paper on dengue vaccines prepared by the SAGE Working Group on Dengue; 2016."},{"key":"10.1016\/j.vaccine.2017.07.045_b0225","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nrmicro.2015.2","article-title":"Dengue vaccine: Hypotheses to understand CYD-TDV-induced protection","volume":"14","author":"Guy","year":"2015","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.vaccine.2017.07.045_b0230","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1056\/NEJMoa1506223","article-title":"Efficacy and long-term safety of a dengue vaccine in regions of endemic disease","volume":"373","author":"Hadinegoro","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2017.07.045_b0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0004821","article-title":"Safety overview of a recombinant live-attenuated tetravalent dengue vaccine: Pooled analysis of data from 18 clinical trials","volume":"10","author":"Gailhardou","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2017.07.045_b0240","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1093\/infdis\/jiv082","article-title":"Robust and balanced immune responses to all 4 dengue virus serotypes following administration of a single dose of a live attenuated tetravalent dengue vaccine to healthy, flavivirus-naive adults","volume":"212","author":"Kirkpatrick","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.07.045_b0245","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1093\/infdis\/jiw067","article-title":"A 12-month-interval dosing study in adults indicates that a single dose of the National Institute of Allergy and Infectious Diseases tetravalent dengue vaccine induces a robust neutralizing antibody response","volume":"214","author":"Durbin","year":"2016","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.07.045_b0250","doi-asserted-by":"crossref","first-page":"698","DOI":"10.4269\/ajtmh.14-0268","article-title":"An adjuvanted, tetravalent dengue virus purified inactivated vaccine candidate induces long-lasting and protective antibody responses against dengue challenge in rhesus macaques","volume":"92","author":"Fernandez","year":"2015","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2017.07.045_b0255","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.4269\/ajtmh.16-0634","article-title":"Phase 1 randomized study of a tetravalent dengue purified inactivated vaccine in healthy adults in the United States","volume":"96","author":"Schmidt","year":"2017","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2017.07.045_b0260","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1093\/infdis\/jiv762","article-title":"Safety and immunogenicity of a tetravalent dengue vaccine candidate in healthy children and adults in dengue-endemic regions: A randomized, placebo-controlled phase 2 study","volume":"213","author":"Sirivichayakul","year":"2016","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.07.045_b0265","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.vaccine.2008.10.086","article-title":"Scientific consultation on cell mediated immunity (CMI) in dengue and dengue vaccine development","volume":"27","author":"Thomas","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.07.045_b0270","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.4049\/jimmunol.175.4.2676","article-title":"Altered cytokine responses of dengue-specific CD4+ T cells to heterologous serotypes","volume":"175","author":"Mangada","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2017.07.045_b0275","doi-asserted-by":"crossref","first-page":"5712","DOI":"10.1016\/j.vaccine.2008.08.019","article-title":"Cell-mediated immunity induced by chimeric tetravalent dengue vaccine in naive or flavivirus-primed subjects","volume":"26","author":"Guy","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.07.045_b0280","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1038\/nm887","article-title":"Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever","volume":"9","author":"Mongkolsapaya","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2017.07.045_b0285","doi-asserted-by":"crossref","first-page":"E4256","DOI":"10.1073\/pnas.1505956112","article-title":"Dengue virus infection elicits highly polarized CX3CR1+ cytotoxic CD4+ T cells associated with protective immunity","volume":"112","author":"Weiskopf","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2017.07.045_b0290","doi-asserted-by":"crossref","first-page":"E2046","DOI":"10.1073\/pnas.1305227110","article-title":"Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8+ T cells","volume":"110","author":"Weiskopf","year":"2013","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.vaccine.2017.07.045_b0295","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1093\/infdis\/jir012","article-title":"Intracellular cytokine production by dengue virus-specific T cells correlates with subclinical secondary infection","volume":"203","author":"Hatch","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.07.045_b0300","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1128\/JVI.02675-12","article-title":"Differential targeting of viral components by CD4+ versus CD8+ T lymphocytes in dengue virus infection","volume":"87","author":"Rivino","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2017.07.045_b0305","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1093\/infdis\/jiv289","article-title":"Human CD8+ T-cell responses against the 4 dengue virus serotypes are associated with distinct patterns of protein targets","volume":"212","author":"Weiskopf","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.07.045_b0310","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1128\/JVI.02129-14","article-title":"The human CD8+ T cell responses induced by a live attenuated tetravalent dengue vaccine are directed against highly conserved epitopes","volume":"89","author":"Weiskopf","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2017.07.045_b0315","doi-asserted-by":"crossref","first-page":"304ra141","DOI":"10.1126\/scitranslmed.aaa3787","article-title":"Dengue virus NS1 triggers endothelial permeability and vascular leak that is prevented by NS1 vaccination","volume":"7","author":"Beatty","year":"2015","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.vaccine.2017.07.045_b0320","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1126\/science.aaa8651","article-title":"Cryo-EM structure of an antibody that neutralizes dengue virus type 2 by locking E protein dimers","volume":"349","author":"Fibriansah","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2017.07.045_b0325","doi-asserted-by":"crossref","first-page":"e01559","DOI":"10.1128\/mBio.01559-15","article-title":"Genotypic differences in dengue virus neutralization are explained by a single amino acid mutation that modulates virus breathing","volume":"6","author":"Dowd","year":"2015","journal-title":"MBio"},{"key":"10.1016\/j.vaccine.2017.07.045_b0330","doi-asserted-by":"crossref","first-page":"e1002111","DOI":"10.1371\/journal.ppat.1002111","article-title":"A dynamic landscape for antibody binding modulates antibody-mediated neutralization of West Nile virus","volume":"7","author":"Dowd","year":"2011","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2017.07.045_b0335","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1126\/science.aac5017","article-title":"Dengue viruses cluster antigenically but not as discrete serotypes","volume":"349","author":"Katzelnick","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2017.07.045_b0340","doi-asserted-by":"crossref","first-page":"5090","DOI":"10.1128\/JVI.00155-16","article-title":"Functional transplant of a dengue virus serotype 3 (DENV3)-specific human monoclonal antibody epitope into DENV1","volume":"90","author":"Messer","year":"2016","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2017.07.045_b0345","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1126\/science.1185181","article-title":"Cross-reacting antibodies enhance dengue virus infection in humans","volume":"328","author":"Dejnirattisai","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2017.07.045_b0350","article-title":"Investigations of the observed efficacy of the CYD tetravalent dengue vaccine in the phase 2b trial in Ratchaburi, Thailand","volume":"91","author":"Jackson","year":"2014","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2017.07.045_b0355","doi-asserted-by":"crossref","first-page":"e88","DOI":"10.1016\/S1473-3099(16)30473-X","article-title":"Dengue: Knowledge gaps, unmet needs, and research priorities","volume":"17","author":"Katzelnick","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2017.07.045_b0360","doi-asserted-by":"crossref","first-page":"e2952","DOI":"10.1371\/journal.pntd.0002952","article-title":"Variability in dengue titer estimates from plaque reduction neutralization tests poses a challenge to epidemiological studies and vaccine development","volume":"8","author":"Salje","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2017.07.045_b0365","doi-asserted-by":"crossref","first-page":"825","DOI":"10.4269\/ajtmh.2009.08-0625","article-title":"Dengue plaque reduction neutralization test (PRNT) in primary and secondary dengue virus infections: How alterations in assay conditions impact performance","volume":"81","author":"Thomas","year":"2009","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2017.07.045_b0370","doi-asserted-by":"crossref","first-page":"7210","DOI":"10.1128\/JVI.03690-13","article-title":"Mechanism and significance of cell type-dependent neutralization of flaviviruses","volume":"88","author":"Mukherjee","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2017.07.045_b0375","doi-asserted-by":"crossref","first-page":"e1486","DOI":"10.1371\/journal.pntd.0001486","article-title":"Development and characterization of a reverse genetic system for studying dengue virus serotype 3 strain variation and neutralization","volume":"6","author":"Messer","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2017.07.045_b0380","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/ni0715-785a","article-title":"A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus","volume":"16","author":"Dejnirattisai","year":"2015","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2017.07.045_b0385","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/emmm.201303404","article-title":"A potent anti-dengue human antibody preferentially recognizes the conformation of E protein monomers assembled on the virus surface","volume":"6","author":"Fibriansah","year":"2014","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.vaccine.2017.07.045_b0390","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nature14130","article-title":"Recognition determinants of broadly neutralizing human antibodies against dengue viruses","volume":"520","author":"Rouvinski","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2017.07.045_b0395","doi-asserted-by":"crossref","first-page":"6341","DOI":"10.1038\/ncomms7341","article-title":"A highly potent human antibody neutralizes dengue virus serotype 3 by binding across three surface proteins","volume":"6","author":"Fibriansah","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2017.07.045_b0400","doi-asserted-by":"crossref","first-page":"7439","DOI":"10.1073\/pnas.1200566109","article-title":"Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions","volume":"109","author":"de Alwis","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2017.07.045_b0405","doi-asserted-by":"crossref","first-page":"e02041-16","DOI":"10.1128\/JVI.02041-16","article-title":"Mapping the human memory B cell and serum neutralizing antibody responses to dengue virus serotype 4 Infection and vaccination","volume":"91","author":"Nivarthi","year":"2017","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2017.07.045_b0410","doi-asserted-by":"crossref","first-page":"e01461","DOI":"10.1128\/mBio.01461-15","article-title":"A new quaternary structure epitope on dengue virus serotype 2 is the target of durable type-specific neutralizing antibodies","volume":"6","author":"Gallichotte","year":"2015","journal-title":"MBio"},{"key":"10.1016\/j.vaccine.2017.07.045_b0415","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/mSphere.00380-16","article-title":"Epitope addition and ablation via manipulation of a dengue virus serotype 1 infectious clone","volume":"2","author":"Gallichotte","year":"2017","journal-title":"mSphere"},{"key":"10.1016\/j.vaccine.2017.07.045_b0420","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1073\/pnas.1213737110","article-title":"Molecular deconvolution of the monoclonal antibodies that comprise the polyclonal serum response","volume":"110","author":"Wine","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2017.07.045_b0425","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1084\/jem.20110740","article-title":"Memory B cells, but not long-lived plasma cells, possess antigen specificities for viral escape mutants","volume":"208","author":"Purtha","year":"2011","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2017.07.045_b0430","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1038\/nm.4224","article-title":"Molecular-level analysis of the serum antibody repertoire in young adults before and after seasonal influenza vaccination","volume":"22","author":"Lee","year":"2016","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2017.07.045_b0435","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1093\/infdis\/jiw309","article-title":"HLA-DRB1 alleles are associated with different magnitudes of dengue virus-specific CD4+ T-cell responses","volume":"214","author":"Weiskopf","year":"2016","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.07.045_b0440","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.it.2015.06.005","article-title":"Utilizing population variation, vaccination, and systems biology to study human immunology","volume":"36","author":"Tsang","year":"2015","journal-title":"Trends Immunol"},{"key":"10.1016\/j.vaccine.2017.07.045_b0445","doi-asserted-by":"crossref","first-page":"5294","DOI":"10.1016\/j.vaccine.2015.03.072","article-title":"Systems vaccinology: Enabling rational vaccine design with systems biological approaches","volume":"33","author":"Hagan","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.07.045_b0450","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.cell.2014.03.031","article-title":"Global analyses of human immune variation reveal baseline predictors of postvaccination responses","volume":"157","author":"Tsang","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2017.07.045_b0455","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1056\/NEJMoa1113425","article-title":"Immune-correlates analysis of an HIV-1 vaccine efficacy trial","volume":"366","author":"Haynes","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2017.07.045_b0460","doi-asserted-by":"crossref","first-page":"e1002181","DOI":"10.1371\/journal.pmed.1002181","article-title":"The long-term safety, public health impact, and cost-effectiveness of routine vaccination with a recombinant, live-attenuated dengue vaccine (Dengvaxia): a model comparison study","volume":"13","author":"Flasche","year":"2016","journal-title":"PLoS Med"},{"key":"10.1016\/j.vaccine.2017.07.045_b0465","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1126\/science.aaf9590","article-title":"Benefits and risks of the Sanofi-Pasteur dengue vaccine: modeling optimal deployment","volume":"353","author":"Ferguson","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2017.07.045_b0470","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.vaccine.2016.10.070","article-title":"Dengue vaccine: WHO position paper, July 2016 \u2013 recommendations","volume":"35","author":"World Health Organization","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.07.045_b0475","unstructured":"World Health Organization. WHO: Weekly epidemiological record Relev\u00e9 \u00e9pid\u00e9miologique hebdomadaire, vol. 21; 2016. doi: 10.1186\/1750-9378-2-15.Voir."},{"key":"10.1016\/j.vaccine.2017.07.045_b0480","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.vaccine.2016.02.004","article-title":"Protective and immunological behavior of chimeric yellow fever dengue vaccine","volume":"34","author":"Halstead","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.07.045_b0485","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1093\/infdis\/jiw340","article-title":"Critique of World Health Organization recommendation of a dengue vaccine","volume":"214","author":"Halstead","year":"2016","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.07.045_b0490","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1093\/oxfordjournals.aje.a120955","article-title":"Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine","volume":"89","author":"Kim","year":"1969","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2017.07.045_b0495","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1126\/science.aab4047","article-title":"Dengue vaccines at a crossroad","volume":"350","author":"Wilder-Smith","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2017.07.045_b0500","unstructured":"WHO. Guidelines on the quality, safety and efficacy of dengue tetravalent vaccines (live, attenuated); 2011."},{"key":"10.1016\/j.vaccine.2017.07.045_b0505","doi-asserted-by":"crossref","first-page":"7121","DOI":"10.1016\/j.vaccine.2015.09.105","article-title":"Clinical evaluation strategies for a live attenuated tetravalent dengue vaccine","volume":"33","author":"Precioso","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.07.045_b0510","doi-asserted-by":"crossref","first-page":"7091","DOI":"10.1016\/j.vaccine.2015.09.053","article-title":"Next generation dengue vaccines: a review of the preclinical development pipeline","volume":"33","author":"Vannice","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.07.045_b0515","first-page":"1","article-title":"Immune correlates for dengue vaccine development","volume":"584","author":"Srikiatkhachorn","year":"2015","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2017.07.045_b0520","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1093\/cid\/cit048","article-title":"Complex correlates of protection after vaccination","volume":"56","author":"Plotkin","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2017.07.045_b0525","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1093\/cid\/cis238","article-title":"Nomenclature for immune correlates of protection after vaccination","volume":"54","author":"Plotkin","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2017.07.045_b0530","unstructured":"Sun W. Assays, immune correlates and dengue vaccines from the regulatory perspective. Summit on Dengue Immune Correlates of Protection, Personal communication;\u00a02016."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17309532?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17309532?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,2,24]],"date-time":"2020-02-24T16:39:19Z","timestamp":1582562359000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17309532"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":107,"journal-issue":{"issue":"36","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S0264410X17309532"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.07.045","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]}}}